Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Plaque Psoriasis Clinical Trials
Plaque Psoriasis clinical trials are recruiting across 63 cities. Here are the cities with the most active studies:
Plaque Psoriasis Trial Phases
14 research organizations are sponsoring plaque psoriasis trials.
About Plaque Psoriasis
Plaque psoriasis is the most common form of psoriasis, characterized by raised, red patches covered with silvery-white scales. It can appear anywhere on the body and affects about 80% of people with psoriasis. Treatment includes topical therapies, phototherapy, and systemic medications including biologics.
Clinical trials are advancing new treatments for plaque psoriasis. Currently, 21 studies are recruiting a combined 7,710 participants across the United States. Research is being conducted by 14 organizations including Bristol-Myers Squibb, AbbVie, Vanda Pharmaceuticals and 11 others.
2026 Plaque Psoriasis Research Landscape
As of July 2026, the plaque psoriasis clinical trial landscape includes 21 actively recruiting studies across 63 cities in the United States. These studies are collectively seeking 7,710 participants, with an average enrollment target of 367 per study.
The research spans multiple phases of development: 6 studies are in PHASE3, 6 studies are in PHASE4, 4 studies are in PHASE2, 2 studies are in PHASE1, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some plaque psoriasis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 14 different organizations, including Bristol-Myers Squibb, AbbVie, Vanda Pharmaceuticals, Psoriasis Research Institute of Guangzhou, Oruka Therapeutics, Inc., and 9 others. The large number of sponsors reflects significant research interest and investment in plaque psoriasis treatment advancement.
Geographically, plaque psoriasis trials are most concentrated in Fountain Valley, California (9 trials); Los Angeles, California (7 trials); Miami, Florida (6 trials); Phoenix, Arizona (5 trials); Fremont, California (5 trials) and 7 other cities.
Featured Plaque Psoriasis Studies
Highlighted recruiting studies for plaque psoriasis, selected by enrollment size and research scope.
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis
A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
The purpose of this study is to understand the comparative effectiveness of deucravacitinib versus apremilast in adults with plaque psoriasis.
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
The objective of this registry is to compare outcomes of risankizumab-exposed pregnancies with those of pregnancies that were not exposed to risankizumab among women with plaque psoriasis, psoriatic arthritis (PsA), Crohn's disease (CD), or other conditions for which risankizumab is an FDA-approved treatment. The registry is designed to estimate the association between risankizumab and maternal, f...
Frequently Asked Questions About Plaque Psoriasis Clinical Trials
Are there plaque psoriasis clinical trials near me?
Yes, there are 21 plaque psoriasis clinical trials currently recruiting across 63+ cities in the United States, including Fountain Valley, California; Los Angeles, California; Miami, Florida. Browse the studies above to find one at a location convenient for you.
How do I join a plaque psoriasis clinical trial?
To join a plaque psoriasis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are plaque psoriasis clinical trials free?
Yes, participation in plaque psoriasis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of plaque psoriasis treatments are being studied?
Current plaque psoriasis clinical trials are testing a range of approaches across PHASE3 (6 studies), PHASE4 (6 studies), PHASE2 (4 studies), PHASE1 (2 studies), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 14 research organizations.
Is it safe to participate in plaque psoriasis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 17, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 17, 2026 · Data from ClinicalTrials.gov